Treatment of Oral Warts in HIV+ Patients
Public ClinicalTrials.gov record NCT00454181. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of Natural Human Interferon Alpha Administered Oromucosally in the Treatment of Oral Warts in HIV-seropositive Subjects Receiving Combination Anti-retroviral Therapy: A Phase 2 Clinical Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a study to test lozenges of interferon-alpha that are dissolved in the mouth as a treatment of oral warts in HIV-positive adults. The hypothesis of this study is that interferon-alpha will be safe and that a higher percentage of subjects given interferon-alpha will experience a complete or nearly complete remission of their oral warts compared to subjects given placebo.
Study identification
- NCT ID
- NCT00454181
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 59 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2007
- Primary completion
- Aug 31, 2009
- Completion
- Sep 30, 2009
- Last update posted
- Sep 15, 2011
2007 – 2009
United States locations
- U.S. sites
- 12
- U.S. states
- 11
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, School of Dentistry | San Francisco | California | 94143 | — |
| Nova Southeastern University College of Dental Medicine | Fort Lauderdale | Florida | 33328-2018 | — |
| Medical College of Georgia School of Dentistry | Augusta | Georgia | 30912-1241 | — |
| University of Illinois at Chicago, College of Dentistry | Chicago | Illinois | 60612 | — |
| University of Kentucky College of Dentistry | Lexington | Kentucky | 40536-0297 | — |
| University of Maryland Baltimore Dental School | Baltimore | Maryland | 21201 | — |
| Division of Oral Medicine and Dentistry, Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| UMDNJ - New Jersey Dental School | Newark | New Jersey | 07108 | — |
| New York University College of Dentistry | New York | New York | 10010 | — |
| University of Pennsylvania School of Dental Medicine | Philadelphia | Pennsylvania | 19104 | — |
| Baylor College of Dentistry | Dallas | Texas | 75246 | — |
| University of Texas Health Science Center at San Antonio | San Antonio | Texas | 78229-3900 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00454181, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 15, 2011 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00454181 live on ClinicalTrials.gov.